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Material and Methods: Between 2013 and 2015 seven pts, 5 
males and 2 females, median age 77 yrs (range: 35-85 yrs) 
received SBRT for primary or metastatic thoracic tumors: 4 
primary lung cancer, 2 mediastinal lymphnode metastasis, 1 
lung metastasis. All pts had a 4D-CT high-resolution 
simulation in 10 respiratory phases for ITV definition. GTV 
and ITV volumes were 4.5-21.4 cm3 and 6.8-39.4 cm3, 
respectively. ITV-PTV margins were 5 mm (median), range: 3-
5 mm. All pts were treated by IG-IMRT volumetric modulated 
arc therapy with 2 modulated arcs. Doses were prescribed 
according to ICRU 83 (median PTV dose) and 99% of PTV had 
to be encompassed by 90% isodose. Total doses were: 20 Gy x 
3 in 1 pt, 12 Gy x 4 in 1 pt, 10 Gy x 5 in 1 pt, 7.5 Gy x 8 in 1 
pt, 6 Gy x 8 in 3 pts. Before CBCT acquisition in all pts 2 
planar (AP-LL) set-up EPID images (kV/MV) were taken for 
preliminary set-up analysis. In absence of rotations on EPID 
imaging, CBCT images (Nr.=44) were acquired for on-line set-
up corrections which were applied before of each 1st SBRT 
treatment arc. Intra-fraction motion was evaluated by 
further CBCT images acquired before starting and at the end 
of the 2nd treatment arc. Structure matching on CBCT was 
automatically done first on bone and then on soft tissue. In-
room mean elapsed time between 1st and last CBCT was 26 
min (range:11-47 min). On-line set-up corrections between 
1st and 2nd arc were applied for errors of ≥ 3mm. For the 
whole series of 7 pts mean differences between planned and 
shifted ITV position along the 3 spatial axes (CC, AP, LL) were 
then calculated on 57 CBCT images, 35 taken between 1st 
and 2nd arc, 22 at the end of 2nd arc. For each patient 
isodose distribution was recalculated on the TPS after 
correction of the isocenter position of the 2 arcs applying the 
mean differences found. Finally, differences in ITV median 
dose, V90, V95, and D98 were calculated. 
 
Results: Mean ITV displacements after the 1st arc were 1.2 
mm ± 1.6 mm, 0.5 mm ± 1.4 mm, 0 mm ± 1.1 mm for CC, AP 
and LL directions, respectively. Mean displacements at the 
end of 2nd arc were 0.1 mm ± 1.4 mm, 0.7 mm ± 1.0 mm, 0.3 
mm ± 0.9 mm for CC, AP and LL directions, respectively. 
Differences between planned and delivered ITV median dose 
ranged from -0.2% to -1.8%; V90 was ≥ 99.8% in all pts, V95 
range was 86.7%-99.7%; D98 was ≥ 92.7% in all pts (Fig. 1). 
 
 
 
Conclusion: Our preliminary analysis of 101 CBCT in 7 pts 
aimed at evaluating intra-fraction organ motion during V-MAT 
SBRT of thoracic targets shows that ITV dosimetric coverage 
is only minimally influenced by intra-fraction ITV 
displacement, provided that on-line corrections are applied 
before each treatment arc. Our findings need to be 
prospectively confirmed in a larger patient series. 
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Purpose or Objective: The inclusion of the Internal Mammary 
Nodes (IMNs) in managing left sided post-mastectomy 
radiotherapy (PMRT) patients has a potential benefit in 
patient outcomes and disease control. Larger treatment 
fields result in higher doses to normal tissue but advancing 
technological techniques, such as the use of Active Breath 
Control (ABC) mean acceptable dose parameters may be 
achieved.  
 
Material and Methods: 50 randomly selected patients with 
left sided breast cancer receiving PMRT underwent CT 
simulation with and without ABC, 100 radiotherapy (RT) plans 
were generated. 30 additional patients requiring left sided 
PMRT with free-breathing (FB) CT simulation scan were 
selected at random as a control group. The IMNs were 
delineated as a target volume within the first 3 intercostal 
spaces as were organs at risk (OAR)- left anterior descending 
coronary artery (LADCA), heart, lung and contralateral breast 
(CB). Modified wide-tangent photon fields, with the inclusion 
of chest wall, IMNs, axilla and supraclavicular fossa as a 4-
field technique were generated for all 130 plans. Statistical 
analysis was completed using Wilcoxon Signed Rank test, 
Mann Whitney test and Pearson and Spearman Correlation 
Coefficients. 
 
Results: IMN PTV coverage in plans with ABC was reduced 
compared to FB (94 vs 98% p<0.001), meeting dosimetric 
criteria for coverage in 90% of plans (range 79-100%). ABC 
significantly reduced dose to all OARs compared to FB - 
median reduction in mean heart dose (MHD) (6.3Gy vs 1.9Gy 
p<0.001), lung V20 (15% vs 11% p<0.001), LADCA max dose to 
0.2cc (49Gy vs 17.8Gy p<0.001) and LADCA mean dose (40Gy 
vs 10Gy p<0.001), with no difference in the D5 to the CB 
(2.2Gy vs 2.1Gy p=0.36).  
In the control vs ABC group, there was no difference in IMN 
PTV coverage (median 94.5% vs 96% p=0.21). There was 
significant median reduction in MHD (3.5Gy vs 1.9Gy 
p<0.001), lung V20 (14% vs 11% p<0.001), LADCA maximum 
dose to 0.2cc (43.9Gy vs 17.8Gy p<0.001) and LADCA mean 
dose (22.6Gy vs 10Gy p<0.001) for the ABC group, but an 
increase in D5 to the CB with the use of ABC (1.5Gy vs 2.1Gy 
p<0.001). 
BMI was not directly correlated with IMN PTV coverage, or 
increase/decrease in OAR constraints.  
 
Conclusion: Our data supports the standard use of ABC in left 
sided PMRT patients that require the inclusion of the IMNs. 
We have demonstrated adequate IMN PTV coverage with 
significant sparing of OARs. The impact of these dosimetric 
reductions on long-term normal tissue effects requires 
further evaluation in prospective studies. 
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Purpose or Objective: Deep inspiration breath hold (DIBH) 
technique may reduce radiation dose to heart and lungs 
during mediastinal radiotherapy (RT) for lymphoma.  
AlignRT is an optical surface tracking system which can be 
used to monitor inspiration depth during DIBH. Data is 
acquired from planning CT scan to generate a 3D surface 
contour of the patient whilst in breath hold (BH). At 
treatment the real-time contour of the patient is monitored 
by cameras and compared to the reference contour.  
We initiated a prospective study to assess the feasibility of 
DIBH with AlignRT in mediastinal lymphoma, and to evaluate 
its dosimetric benefits, compared to free breathing (FB) RT. 
This is the first report of AlignRT use in this indication. 
 
Material and Methods: Eligible patients were due to receive 
RT to the mediastinum for Hodgkin or high grade non Hodgkin 
lymphoma.  
Patients were positioned supine on a thoracic board with 
arms raised. After coaching FB and BH CT scans were 
performed. 3D conformal plans were produced for both FB 
and DIBH volumes for each patient and compared in terms of 
PTV coverage (V95, D95), cardiac doses (MHD, V30, V15), 
lung doses (MLD,V20,V5), spinal cord max. dose and breast 
doses in females (mean, V10,V5). The optimal plan was 
selected for treatment. Data was then transferred to the 
AlignRT software. 
Feasibility was determined by the proportion of patients able 
to manage the technique, and the incidence & nature of 
setup errors.  
 
Results: Between March & September 2015 8 patients were 
eligible for DIBH RT. 1 patient could not maintain BH at 
planning and proceeded with FB RT. For another cardiac 
constraints could not be met with a conformal plan and 
treatment changed to intensity modulated RT (FB). For 6 
patients DIBH and FB plans were created & compared (see 
table). Prescribed dose was 30.6Gy/ 17 #. 
PTV coverage was similar for DIBH and FB. MLD was 
significantly lower in DIBH plans (mean difference 1.58Gy). 
Lung V20 was also reduced by 6.45%. Lung V5 was reduced by 
3.25% but the difference was not significant. Cardiac doses 
were better in the DIBH plans with a reduction in MHD of 
2.49Gy, and V15 by 10.44%. There was no significant 
difference in breast or spinal cord doses. In all cases the DIBH 
plan was chosen for treatment. 
 
Set up issues were encountered in 2/6 DIBH patients early in 
treatment. These were not correctable & required replans. 
Both completed treatment with the new plans without 
incident. Investigation concluded the most likely cause was 
an exaggerated and hard to reproduce BH during the planning 
CT. Patient instructions have been revised . 
Conclusion: Our early experience indicates that DIBH RT 
using Align RT is feasible. A minority of patients may not 
tolerate DIBH and careful coaching is needed to achieve a 
reproducible level of deep inspiration. DIBH RT can reduce 
radiation doses to heart and lungs during mediastinal RT, 
without any increase in breast dose or compromise to PTV 
coverage. 
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Purpose or Objective: To propose a comfortable, harmless 
and stable method to guide the hypnosis for the control of 
respiratory motion during radiotherapy. 
 
Material and Methods: The virtual reality (VR) technology 
was applied in the hypnosis guidance to control the 
respiratory motion. A VR demo was made depending on a pre-
designed hypnosis scene, which follows the Stanford hypnotic 
susceptibility scale1 and the experienced design of 
hypnotists, to make volunteers relax. 46 healthy volunteers, 
including 22 female and 24 male, are taken in the hypnosis 
experiments. The respiratory motion for each volunteer was 
recorded, which takes 10 min before hypnosis (BH) and 20 
min in VR-guide hypnosis state (VRGHS) and 10 min after 
hypnosis (AH). BH and AH are united into normal state (NS). 
 
Results: Two comparative experiments were conducted to 
study the difference of amplitudes of respiratory motion 
between NS and VRGHS. Obvious difference has been 
observed between VRGHS and NS as a whole. As a result, 
compared with NS, the mean amplitudes of respiratory waves 
in VRGHS reduces 18.8% and standard deviation (STD) reduces 
20.7%. Similarly, the female volunteers group drops 16.8% in 
mean value and 23.6% in STD, and the male volunteers group 
has a mean deduction of 20.9% in amplitudes, with a drop of 
17.7% in STD. In addition, 15/22 female show high grade 
significant (p<0.0005) difference between VRGHS and NS, 
20/24 in male. Conclusively, it’s showed that the statistical 
differences of VRGHS are obviously, lower than NS. 
 
